Такзайро
раствор для подкожного введения в предварительно заполненном шприце
LanadelumabЛанаделумаб, , азаспирия хлорид
Prescription only
About the medicine
- Active ingredients
- Lanadelumab + Ланаделумаб, , азаспирия хлорид
- INN
- , ланаделумаб
- Strength
- 300 мг
- Dosage form
- раствор для подкожного введения в предварительно заполненном шприце
- Manufacturer
- 1. Vetter Pharma-Fertigung GmbH & Co. KG, 2. Takeda Pharmaceuticals International AG-Ireland Branch, 3. Takeda Manufacturing Austria AG (1. Германия, 2. Ирландия, 3. Австрия)
- Dispensing
- Prescription only
- Registration certificate
- ЛП-№008643-РГ-KZ
- Registered
- 20 Feb 2025
- Registration valid until
- 20 Feb 2030
- Country of registration
- Kazakhstan
Package leaflet
There is no leaflet with these active ingredients in the reference yet. Read the leaflet in the pack and ask a doctor or pharmacist.
This is reference information and does not replace a doctor's advice. Do not self-medicate: read the leaflet and ask a specialist before use.
Source: State Register of Medicines of the Republic of Kazakhstan (register.ndda.kz).